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INTRODUCTION 
Abnormal fetal growth is a leading cause of perinatal 
morbidity and mortality in both developed and 
developing countries. It has been suggested that a low 
first-trimester measurement of Crown-Rump Length 
(CRL) in pregnancies dated by last menstrual period is 
linked with adverse outcome such as prematurity and 
fetal growth restriction.
1 
A majority of adverse pregnancy 
outcomes such as second trimester abortions, preterm 
births, IUGR (Intra-uterine growth restriction), Small for 
Gestational Age (SGA), preeclampsia and perinatal 
deaths are still alarming problems in our country. Also, 
premature, SGA and growth restricted babies are prone to 
long- term poor cardiovascular and neurological 
prognosis, associated with increased neonatal morbidity 
and mortality.
2,3 
If we could determine the sonographic 
predictive factors of adverse pregnancy outcomes with 
this study, it would be helpful in timely intervention 
thereby, preventing these problems. This would lead to a 
healthier population reducing the burden on the health 
system. 
ABSTRACT 
 
Background: The Objective of this study was to evaluate the association of BPD at 11-14 weeks and pregnancy 
outcome and to determine the role of incremental BPD growth from 11-14 weeks and 17-20 weeks in pregnancy 
outcome. 
Methods: Women (n=910) with singleton pregnancies were included in this prospective observational study after an 
early anomaly scan (11 to 14 weeks). Outcomes noted were the incidence of adverse events and the neonatal birth 
weight. 
Results: Irrespective of their original BPD at 11 to 14 weeks, fetuses had acquired optimum BPD growth rate on a 
follow up scan at 17-20 weeks, i.e., a majority of them fell in the 10
th
 to 90
th
 percentile group (P value <0.001). 
Fetuses with BPD below the 10
th
 percentile were small for gestational age (SGA) at birth despite an optimal growth 
rate. Also, a significant majority of the fetuses with BPD in the 10
th
 to 90
th
 percentile were Appropriate for 
Gestational Age (AGA) at birth. 
Conclusion: The BPD at 11 to 14 weeks scan predicts the incidence of SGA and AGA babies, independent of BPD 
growth rates between first and second trimester. The BPD growth rates were neither significantly different nor 
predictive of the birth weight or adverse pregnancy outcomes.  
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Generally, it is assumed that the variations in fetal growth 
occur during the second half of pregnancy. But, a 
considerable amount of fetal growth occurs during the 
early part of pregnancy also. Fetal growth in the first 14 
weeks occurs by the process of hyperplasia, from 14-32 
weeks by the process of hyperplasia and hypertrophy, and 
thereafter by the process of hypertrophy alone. Moreover, 
the genetic growth potential of each fetus is reflected in 
its early size and growth.  
Hence, we set out to study and compare the effects of 
diminished as well as increased early pregnancy size and 
growth, as assessed from measurements in the first and 
second trimesters, on the pregnancy outcome. We 
hypothesized that at these early gestations, the rate of 
fetal growth could be a better predictor of subsequent 
pregnancy outcome than the actual size for a particular 
gestation.   
METHODS 
A total of 910 women were enrolled in our prospective 
observational study from November, 2011 to September, 
2012 at our tertiary care center following an early 
anomaly scan (11-14 weeks). We excluded those with 
multiple pregnancies, chronic hypertension, pre-
gestational diabetes and a history of any bleeding per 
vaginum in the first trimester. We also excluded women 
with questionable dating. For all those included in our 
study, gestational age was established based on either a 
reliable last menstrual period (LMP) date or a 
transvaginal ultrasound between 6 and 10 weeks or both.  
Prior to enrollment, ethical clearance for the study was 
obtained from the institutional ethics committee.  
After obtaining a written informed consent, a detailed 
medical history was taken. General physical examination 
including weight, height and BMI, systemic examination 
including cardiovascular and respiratory system, and an 
obstetric examination were done. The recruited patients 
had an early anomaly scan at 11-14 weeks and a routine 
anomaly scan at 17-20 weeks of gestation, and were 
followed up till their delivery at our hospital.   
The biometric growth parameters of the fetus were 
measured using Toshiba Nimio ultrasound machine with 
a 6.5 MHz transvaginal transducer and a 5 MHz trans-
abdominal transducer for measurement of Biparietal 
Diameter (BPD). 
The patients were divided as per BPD measured at 11- 14 
weeks scan into three groups: Group 1 (BPD below the 
10
th
 percentile), group 2 (BPD between 10
th
-90
th
 
percentiles) and group 3 (BPD above the 90
th
 percentile). 
The interval growth from the two scan findings was 
measured and expressed in terms of an incremental BPD 
growth in millimeters per day and patients were grouped 
as group A (Growth rate below the 10
th
 percentile), group 
B (Growth rate between 10
th
 -90
th
 percentiles) and group 
C (Growth rate above the 90
th
 percentile). 
These patients were followed up to observe obstetric 
outcomes such as incidence of second trimester abortion, 
preterm birth, gestational hypertension, preeclampsia, 
gestational diabetes mellitus and IUGR. We also noted 
neonatal morbidity in terms of birth weight (SGA, AGA 
and LGA) and incidence of fetal anomalies and stillborn. 
Statistical analysis was done using SPSS-16 package and 
a P value of less than 0.05 was considered significant.  
RESULTS 
Of the 910 women enrolled, only 723 women delivered in 
our hospital and the outcomes of these pregnancies were 
analyzed. The patient characteristics in the three BPD and 
the three BPD growth rate groups were matched as 
shown in Tables 1 and 2. 
 
Table 1: Patient characteristics in the BPD Groups (N=723).  
Patient characteristics 
Group 1 (n=79) 
Mean ± SD 
Group 2 (n=557) 
Mean ± SD 
Group 3 (n=87) 
Mean ± SD 
P value 
Mean age (y) 27.29 ± 3.09 27.47 ± 1.16 27.97 ± 3.01 0.555 
Mean weight (kg) 51.20 ± 5.79 51.75 ± 2.19 51.53 ± 5.56 0.399 
Mean height (cm) 151.87 ± 17.19 152.26 ± 6.45 152.55 ± 16.44 0.401 
BMI (kg/m
2
) 22.19 ± 2.51 22.32 ± 0.94 22.09 ± 2.38 0.634 
Parity 
• Primigravida 59 (74.7%) 378 (67.9%) 51 (58.6%) 
0.081 
• Multigravida 20 (25.3%) 179 (32.1%) 36 (61.4%) 
 
The incidence of maternal obstetrics complications like 
gestational hypertension, preeclampsia and gestational 
diabetes mellitus in all three BPD as well as the three 
BPD growth rate groups was similar. 
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The mean gestational age at delivery was found to be 
37.14 ± 1.38 weeks. The mean birth weight was 2719 ± 
101.20 grams as mentioned in Table 3. Out of 723 
pregnancies, 12 (2%) aborted and 15 (2.5%) were 
stillborn. But over 96% were live births with an incidence 
of 5 neonatal deaths.  
 
Table 2: Patient characteristics in the BPD growth rate groups (N=723). 
Patient characteristics 
Group A (n=72) 
Mean ± SD 
Group B (n=582) 
Mean ± SD 
Group C (n=69) 
Mean ± SD 
P value 
Mean age (y) 28.02 ± 3.32 27.44 ± 1.13 27.59 ± 3.34 0.642 
Mean weight (kg) 52.40 ± 6.21 51.60 ± 2.14 51.48 ± 6.24 0.467 
Maternal height (cm) 153.11 ± 18.17 152.31 ±  6.31 150.89 ± 18.29 0.547 
Maternal BMI (Kg/sq.m) 22.35 ± 2.65 22.23 ± 0.92 22.63 ± 2.74 0.704 
Parity 
• Primigravida 44 (61.11%) 396 (68.04%) 48 (69.56%) 
0.460 
• Multigravida 28 (38.89%) 186 (31.96%) 21 (30.44%) 
 
Table 3: Birth weight in the BPD groups (N=723).  
         Body  
         weight 
 
BPD group 
SGA 
(n=145) 
AGA 
(n=565) 
LGA 
(n=13) 
Group 1 
(n=79) (%) 
25 
(31.6%) 
53 
(67.6%) 
1 
(1.3%) 
Group 2 
(n=557) (%) 
102 
(18.3%) 
447 
(80.3%) 
8 
(1.4%) 
Group 3 
(n=87) (%) 
18 
(20.7%) 
65 
(74.7%) 
4 
(4.6%) 
P value 0.021 0.021 0.111 
*Group 1 - BPD <10th percentile 
Group 2 - BPD = 10th-90th percentile 
Group 3 - BPD >90th percentile 
Table 4: Comparison of BPD groups and BPD growth 
rate group.  
BPD growth 
rate groups** 
 
BPD groups* 
Group A 
(n=72) 
(%) 
Group B 
(n=582) 
(%) 
Group C 
(n=69) 
(%) 
P 
Value 
Group 1 
(n=79) (%) 
15 
(19%) 
50 
(63.3%) 
14 
(17.7%) 
<0.001 
Group 2 
(n=557) (%) 
48 
(8.6%) 
455 
(81.7%) 
54 
(9.7%) 
Group 3 
(n=87) (%) 
9 
(10.3%) 
77 
(88.5%) 
1 
(1.1%) 
P Value 0.016 <0.001 0.001 
*Group 1 - BPD <10th percentile 
Group 2 - BPD = 10th-90th percentile 
Group 3 - BPD >90th percentile 
**Group A - Growth rate <10th percentile 
Group B - Growth rate = 10th-90th percentile 
Group C - Growth rate >90th percentile 
It was noted that the incidence of fetal obstetric 
complications IUGR, macrosomia, preterm delivery, 
stillbirth and neonatal deaths were similar in all the three 
BPD as well as the BPD growth rate groups. A majority 
of the cases in each of the groups did not have any of the 
complications and among those who did, no significance 
could be established. 
Out of the 79 patients belonging to the BPD group 1, 
twenty five (nearly one third) delivered SGA babies. This 
was significantly more than those belonging to groups 2 
or 3 (18.3 and 20.7 percent respectively). Again, among 
patients belonging to group 2, a significant majority 
delivered AGA babies as compared to groups 1 or 3. 
Hence, it can be deduced that an early scan showing a 
normal measurement of BPD was associated with an 
increased chance of having an AGA baby. Similarly, an 
early BPD measurement, lesser than the 10
th
 percentile, 
was seen to be associated with an increased incidence of 
SGA babies.  
Out of 145 SGA babies, 65 babies were diagnosed to 
have IUGR, and 80 were constitutionally small. Out of 65 
IUGR fetuses, 24 fetuses had Doppler changes; raised 
indices were seen in 9 (6.2%), 1 had increased MCA flow 
(0.7%), and an absent end diastolic flow was seen in 14 
(9.7%).   
It was noted that the fetuses, irrespective of their original 
BPD measurement in the 11 to 14 weeks scan, had 
acquired optimum BPD growth rate on follow up scan at 
17-20 weeks, i.e., majority of them fell into the 10
th
 to 
90
th
 percentile group (P value <0.001). So, the BPD 
growth rate, in the time period between the two scans, 
i.e., 11 to 14 weeks scan and 17 to 20 weeks scan, does 
not depend on the original BPD measurement. Also it 
was noted that, fetuses with a BPD below the 10
th
 
percentile, belonging to group 1, were SGA despite an 
optimal growth rate. Also, a significant majority of the 
fetuses belonging to group 2 (BPD being 10
th
 to 90
th
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percentile) were appropriate for gestational age at birth 
(Table 4). 
DISCUSSION 
The In our study, we assessed the relation between early 
fetal size as well as early fetal growth and subsequent 
adverse pregnancy outcomes using BPD measurements  
in the first and second trimesters, longitudinally assessed 
by ultrasound. 
An early scan showing a normal measurement of BPD 
was associated with an increased chance of having an 
AGA baby. Similarly, an early BPD measurement, lower 
than the 10
th
 percentile, was associated with an increased 
incidence of SGA babies.  
We noted that the early fetal size as well growth rate 
could not be used to predict incidence of preterm labor. 
Fetal complications like intrauterine growth restriction, 
macrosomia and preterm delivery were similar in all three 
BPD groups as well as three BPD growth rate groups. 
Hence, these complications could not be predicted by 
measurement of BPD or BPD growth rate. 
Previous publications on growth in early pregnancy have 
looked at early fetal size in relation to the last menstrual 
period. However, there would be an inevitable factor of 
error if we did not consider the day of conception which 
is possible only if assisted reproductive technology was 
used.
4-8 
By using two sequential ultrasound measurements 
of the BPD, the method used in our study becomes 
independent of gestational-age error. 
The central finding of our study is that there is a 
significant relation between the BPD measured at 11 to 
14 weeks and the development of SGA and AGA babies. 
The restricted growth of the fetus in very early pregnancy 
may be causally related to these outcomes. 
Traditional thinking is that early fetal growth is 
principally controlled by genetic factors and occurs at a 
constant exponential rate with little biological variation; 
IUGR has been assumed to occur mainly in the latter half 
of pregnancy.
1 
Our study supports this view, showing that 
fetal growth rate between the first and second trimesters 
does vary between fetuses and is not associated with 
perinatal death and low birth weight. 
The maternal complications like gestational hypertension, 
preeclampsia and gestational diabetes were found to have 
similar incidence in all BPD as well as BPD growth rate 
groups. The overall incidence of these complications 
among patients in our study was roughly 5%. 
The prevalence of pre-eclampsia was 5.5% in our study 
group, which is higher than the 3-5% prevalence 
normally reported.
10 
The high prevalence reflects the fact 
that there is an increase incidence of preeclampsia in our 
ethnic group. 
We chose BPD over CRL in our study as BPD is 
repeatedly measured throughout pregnancy as compared 
to CRL, which is not measured beyond 12 weeks as the 
flexion of fetal spine renders it less accurate. Also it 
would be difficult to compare the CRL measured in 1
st
 
trimester with BPD measured in 2
nd
 trimester for the 
same fetus in order to obtain a precise growth rate. BPD 
can be measured at 8 weeks. 
In our study, growth rate was adjusted only for 
gestational age. More complex models, additionally 
including biochemical markers, uterine artery pulsatility 
index and adjustment for fetal gender and parental 
characteristics, would most likely identify at-risk 
pregnancies more accurately. Such a model is outside the 
scope of our study, but would probably be a valuable 
clinical tool, enabling resources to be focused more 
accurately on the pregnancies at highest risk. 
In the Copenhagen first trimester study
 
done by Pederson 
et al., the BPD measurements at 11-14 and 17-21 weeks 
from 8215 singleton pregnancies at the Copenhagen 
University hospital, Denmark were analyzed.
11 
They 
found a significant relationship between the growth rate 
of BPD from the first to the second trimester and adverse 
pregnancy outcome. Low growth rates were associated 
with an increased odds ratio for perinatal death and 
IUGR, while high growth rates are associated with an 
increased odds ratio for macrosomia and preterm 
delivery. Growth rate showed no association with pre-
eclampsia.   
Gordon et al. studied the relation between the outcome of 
4229 pregnancies and the difference between the 
measured and the expected CRL in the first trimester, 
expressed as equivalent days of growth.
9 
They found that 
a first-trimester CRL that was two to six days smaller 
than expected was associated with an increased risk of a 
birth weight below 2500 g, a birth weight below 2500 g 
at term, a birth weight below the fifth percentile for 
gestational age, and delivery between 24 and 32 weeks of 
gestation. They concluded suboptimal first-trimester 
growth may be associated with low birth weight, low 
birth weight percentile and premature delivery.  
Vafae et al. from Iran included 269 women attending an 
antenatal clinic for a fetal sonographic examination 
between 9 and 14 weeks of gestation, who were followed 
up to delivery and similar outcomes as those in our study 
were recorded.
12 
The only difference was that instead of 
the BPD, the Crown Rump Length (CRL) was measured. 
A significant relation was established between low birth 
weight and low CRL recording. Difference between 
observed and expected CRL (days) showed significant 
associations by low birth weight (relative risk = 0.257), 
abortion (relative risk = 4.850) and need for an 
emergency termination of pregnancy (relative risk = 
0.367). 
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In conclusion, we found a significant relationship 
between the BPD measurement done during the 11 to 14 
weeks scan and the development of SGA and AGA 
babies, irrespective of BPD growth rates. These findings 
underline the importance of focusing on first trimester 
ultrasonography instead of later pregnancy when 
irreparable damage might already have occurred. 
 
Table 5: Comparison of our study with other studies.  
Parameters Present study Copenhagen study
11
 Gordon et al.
9
 Vafae et al.
12
 
Type of study Prospective Prospective Prospective Prospective 
Number of subjects 723 8215 4229 269 
Parameter recorded in the first 
trimester and second trimesters 
BPD and BPD 
growth rate 
BPD growth rate 
First trimester 
CRL 
First trimester 
CRL 
Outcome noted 
Low BPD is 
associated with 
SGA, but not 
preterm labor 
Low growth rates are 
associated with 
perinatal death and 
IUGR 
Smaller CRL 
was associated 
with low birth 
weight and 
preterm labor 
Smaller CRL 
was 
associated 
with low birth 
weight 
 
Funding: No funding sources 
Conflict of interest: None declared 
Ethical approval: The study was approved by the 
institutional ethics committee 
REFERENCES 
1. Paz I, Laor A, Gale R, Harlap S, Stevenson DK, 
Seidman DS. Term infants with fetal growth 
restriction are not at increased risk for low 
intelligence scores at age 17 years. J Pediatr. 
2001;138(1):87-91.  
2. Jacobsson B, Ahlin K, Francis A. Cerebral palsy 
and restricted growth status at birth: population-
based case-control study. Br J Obstet Gynecol. 
2008;115:1250-5.  
3. Gardosi J. Intrauterine growth restriction: new 
standards for assessing adverse outcome. Best Pract 
Res Clin Obstet Gynecol. 2009;23:741-9.  
4. Gardosi J, Figueras F, Clausson B. The customised 
growth potential: an international research tool to 
study the epidemiology of fetal growth. Paediatr 
Perinat Epidemiol. 2011;25(1):2-10.  
5. Gardosi J, Clausson B, Francis A. The value of 
customised centiles in assessing perinatal mortality 
risk associated with parity and maternal size. Br J 
Obstet Gynaecol. 2009;116:1356-63.  
6. Gardosi J, Francis A. Adverse pregnancy outcome 
and association with smallness for gestational age 
by customised and population based birth-weight 
percentiles. Am J Obstet Gynecol. 2009;201:28,e1-
8. 
7. Godfrey K, Robinson S, Barker DJ, Osmond C, Cox 
V. Maternal nutrition in early and late pregnancy in 
relation to placental and fetal growth. Br Med J. 
1996;312(7028):410-4.  
8. Gardosi J, Mongelli M, Wilcox M, Chang A. An 
adjustable fetal weight standard. Ultrasound Obstet 
Gynecol. 1995;6:168-74.  
9. Gordon CS, Malcolm FS, Mcnay MB, Fleming EJ. 
First-trimester growth and the risk of low birth 
weight. N Engl J Med. 1998;339:1817-22. 
10. National Institute for Health and Clinical 
Excellence. NICE guideline CG6: antenatal care: 
routine care for the healthy pregnant woman, 2010. 
Available at: 
www.nice.org.uk/nicemedia/live/11947/40115/4011
5.pdf. Accessed 8 December 2010.  
11. Pedersen NG, Wojdemann KR, Scheike T, Tabor A. 
Fetal growth between the first and second trimesters 
and the risk of adverse pregnancy outcome. 
Ultrasound Obstet Gynecol. 2008;32:147-54.  
12. Vafae H, Hosseini A, Zolghadri J, Samsami A. 
Correlation of first trimester fetal crown-rump 
length and outcome of pregnancy and birth weight. 
Int J Gynecol Obstet. 2012 Nov;119(2):141-4.   
 
 
 
 
 
 
DOI: 10.5455/2349-3259.ijct20140506 
Cite this article as: Jamdade KP, Amin S, Ferrao SR. 
Biparietal diameter (BPD) growth rate between the 
first and second trimester as a predictor of poor 
obstetric and neonatal outcome among the Indian 
population. Int J Clin Trials 2014;1:22-6. 
